Annual EBIT
-$10.11 M
-$178.00 K-1.79%
December 1, 2024
Summary
- As of March 10, 2025, ARTL annual earnings before interest & taxes is -$10.11 million, with the most recent change of -$178.00 thousand (-1.79%) on December 1, 2024.
- During the last 3 years, ARTL annual EBIT has fallen by -$6.07 million (-150.51%).
- ARTL annual EBIT is now -66400.00% below its all-time high of -$15.20 thousand, reached on August 31, 2015.
Performance
ARTL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.81 M
-$2.62 M-219.00%
December 1, 2024
Summary
- As of March 10, 2025, ARTL quarterly earnings before interest & taxes is -$3.81 million, with the most recent change of -$2.62 million (-219.00%) on December 1, 2024.
- Over the past year, ARTL quarterly EBIT has dropped by -$1.30 million (-51.75%).
- ARTL quarterly EBIT is now -122.94% below its all-time high of $16.61 million, reached on March 1, 2009.
Performance
ARTL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$10.11 M
-$572.00 K-6.00%
December 1, 2024
Summary
- As of March 10, 2025, ARTL TTM earnings before interest & taxes is -$10.11 million, with the most recent change of -$572.00 thousand (-6.00%) on December 1, 2024.
- Over the past year, ARTL TTM EBIT has increased by +$847.00 thousand (+7.73%).
- ARTL TTM EBIT is now -116.84% below its all-time high of $60.04 million, reached on June 1, 2009.
Performance
ARTL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ARTL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.8% | -51.8% | +7.7% |
| 3 y3 years | -150.5% | -49.4% | -18.2% |
| 5 y5 years | -115.7% | -165.5% | -111.2% |
ARTL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -150.5% | at low | -219.0% | at low | -17.1% | +7.7% |
| 5 y | 5-year | -214.9% | at low | -300.7% | at low | -119.7% | +7.7% |
| alltime | all time | <-9999.0% | at low | -122.9% | at low | -116.8% | +7.7% |
Artelo Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$10.11 M(+1.8%) | -$3.81 M(+219.0%) | -$10.11 M(+6.0%) |
| Sep 2024 | - | -$1.20 M(-52.4%) | -$9.54 M(-13.0%) |
| Jun 2024 | - | -$2.51 M(-3.0%) | -$10.96 M(+7.1%) |
| Mar 2024 | - | -$2.59 M(-20.1%) | -$10.23 M(+3.0%) |
| Dec 2023 | -$9.93 M(-1.5%) | -$3.24 M(+23.9%) | -$9.93 M(-1.0%) |
| Sep 2023 | - | -$2.61 M(+46.5%) | -$10.03 M(+3.0%) |
| Jun 2023 | - | -$1.78 M(-22.2%) | -$9.74 M(-6.6%) |
| Mar 2023 | - | -$2.29 M(-31.4%) | -$10.43 M(+3.4%) |
| Dec 2022 | -$10.08 M(+149.8%) | -$3.34 M(+43.6%) | -$10.08 M(+8.5%) |
| Sep 2022 | - | -$2.33 M(-5.9%) | -$9.29 M(+5.0%) |
| Jun 2022 | - | -$2.47 M(+27.0%) | -$8.85 M(+2.5%) |
| Mar 2022 | - | -$1.95 M(-23.7%) | -$8.63 M(+0.9%) |
| Dec 2021 | -$4.04 M(-45.7%) | - | - |
| Nov 2021 | - | -$2.55 M(+35.5%) | -$8.55 M(+15.0%) |
| Aug 2021 | -$7.44 M(+58.7%) | -$1.88 M(-16.4%) | -$7.44 M(+13.0%) |
| May 2021 | - | -$2.25 M(+20.6%) | -$6.58 M(+24.6%) |
| Feb 2021 | - | -$1.87 M(+30.0%) | -$5.28 M(+10.4%) |
| Nov 2020 | - | -$1.44 M(+39.7%) | -$4.79 M(+2.1%) |
| Aug 2020 | -$4.69 M(+46.0%) | -$1.03 M(+8.0%) | -$4.69 M(+1.6%) |
| May 2020 | - | -$951.40 K(-30.6%) | -$4.61 M(+0.2%) |
| Feb 2020 | - | -$1.37 M(+2.6%) | -$4.60 M(+15.4%) |
| Nov 2019 | - | -$1.34 M(+40.2%) | -$3.99 M(+24.3%) |
| Aug 2019 | -$3.21 M(+37.0%) | -$953.40 K(+1.3%) | -$3.21 M(+8.9%) |
| May 2019 | - | -$941.30 K(+24.2%) | -$2.95 M(+14.1%) |
| Feb 2019 | - | -$757.90 K(+36.1%) | -$2.58 M(-1.5%) |
| Nov 2018 | - | -$556.90 K(-19.3%) | -$2.62 M(+11.9%) |
| Aug 2018 | -$2.34 M | -$690.10 K(+19.4%) | -$2.34 M(+32.5%) |
| May 2018 | - | -$577.90 K(-27.6%) | -$1.77 M(+37.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2018 | - | -$798.50 K(+188.2%) | -$1.29 M(+157.2%) |
| Nov 2017 | - | -$277.10 K(+139.7%) | -$500.40 K(+114.9%) |
| Aug 2017 | -$232.80 K(+683.8%) | -$115.60 K(+20.8%) | -$232.80 K(+91.6%) |
| May 2017 | - | -$95.70 K(+697.5%) | -$121.50 K(+294.5%) |
| Feb 2017 | - | -$12.00 K(+26.3%) | -$30.80 K(+28.9%) |
| Nov 2016 | - | -$9500.00(+120.9%) | -$23.90 K(-19.3%) |
| Aug 2016 | -$29.70 K(+95.4%) | -$4300.00(-14.0%) | -$29.60 K(-1.0%) |
| May 2016 | - | -$5000.00(-2.0%) | -$29.90 K(+9.1%) |
| Feb 2016 | - | -$5100.00(-66.4%) | -$27.40 K(-3.9%) |
| Nov 2015 | - | -$15.20 K(+230.4%) | -$28.50 K(+86.3%) |
| Aug 2015 | -$15.20 K(-0.7%) | -$4600.00(+84.0%) | -$15.30 K(+36.6%) |
| May 2015 | - | -$2500.00(-59.7%) | -$11.20 K(-33.3%) |
| Feb 2015 | - | -$6200.00(+210.0%) | -$16.80 K(-2.3%) |
| Nov 2014 | - | -$2000.00(+300.0%) | -$17.20 K(+13.2%) |
| Aug 2014 | -$15.30 K | -$500.00(-93.8%) | -$15.20 K(+3.4%) |
| May 2014 | - | -$8100.00(+22.7%) | -$14.70 K(+122.7%) |
| Feb 2014 | - | -$6600.00(-100.0%) | -$6600.00(-100.0%) |
| Jun 2011 | - | $13.44 M(+3.6%) | $53.67 M(-1.6%) |
| Mar 2011 | - | $12.97 M(-3.5%) | $54.56 M(-1.4%) |
| Dec 2010 | - | $13.44 M(-2.8%) | $55.34 M(-0.7%) |
| Sep 2010 | - | $13.82 M(-3.5%) | $55.74 M(+0.0%) |
| Jun 2010 | - | $14.33 M(+4.2%) | $55.73 M(+0.9%) |
| Mar 2010 | - | $13.75 M(-0.6%) | $55.21 M(-4.9%) |
| Dec 2009 | - | $13.84 M(+0.2%) | $58.07 M(-1.5%) |
| Sep 2009 | - | $13.81 M(+0.0%) | $58.95 M(-1.8%) |
| Jun 2009 | - | $13.81 M(-16.9%) | $60.04 M(+29.9%) |
| Mar 2009 | - | $16.61 M(+12.9%) | $46.23 M(+56.1%) |
| Dec 2008 | - | $14.72 M(-1.2%) | $29.61 M(+98.8%) |
| Sep 2008 | - | $14.90 M | $14.90 M |
FAQ
- What is Artelo Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Artelo Biosciences?
- What is Artelo Biosciences annual EBIT year-on-year change?
- What is Artelo Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Artelo Biosciences?
- What is Artelo Biosciences quarterly EBIT year-on-year change?
- What is Artelo Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Artelo Biosciences?
- What is Artelo Biosciences TTM EBIT year-on-year change?
What is Artelo Biosciences annual earnings before interest & taxes?
The current annual EBIT of ARTL is -$10.11 M
What is the all time high annual EBIT for Artelo Biosciences?
Artelo Biosciences all-time high annual earnings before interest & taxes is -$15.20 K
What is Artelo Biosciences annual EBIT year-on-year change?
Over the past year, ARTL annual earnings before interest & taxes has changed by -$178.00 K (-1.79%)
What is Artelo Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of ARTL is -$3.81 M
What is the all time high quarterly EBIT for Artelo Biosciences?
Artelo Biosciences all-time high quarterly earnings before interest & taxes is $16.61 M
What is Artelo Biosciences quarterly EBIT year-on-year change?
Over the past year, ARTL quarterly earnings before interest & taxes has changed by -$1.30 M (-51.75%)
What is Artelo Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of ARTL is -$10.11 M
What is the all time high TTM EBIT for Artelo Biosciences?
Artelo Biosciences all-time high TTM earnings before interest & taxes is $60.04 M
What is Artelo Biosciences TTM EBIT year-on-year change?
Over the past year, ARTL TTM earnings before interest & taxes has changed by +$847.00 K (+7.73%)